Optochemical Sensor Systems for In-Vivo Continuous Monitoring of Blood Gases in Adipose Tissue and in Vital Organs by Merima Čajlaković et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Optochemical Sensor Systems for In-Vivo 
Continuous Monitoring of Blood Gases in 
Adipose Tissue and in Vital Organs 
Merima Čajlaković1, Alessandro Bizzarri1, Gijs H. Goossens2, Igor Knez3, 
Michael Suppan1, Ismar Ovčina3 and Volker Ribitsch1  
1Joanneum Research Forschungsgesellschaft mbH,  
MATERIALS - Institute for Surface Technologies and Photonic, Sensorsystems, Graz, 
2Department of Human Biology, NUTRIM School for Nutrition,  
Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht,  
3Department of Cardiac Surgery, University Clinic of Surgery,  
Medical University Graz, Graz,  
2The Netherlands  
1,3Austria 
1. Introduction 
Sensors capable of determining both oxygen and carbon dioxide partial pressure, as well as 
pH in blood, are of particular interest with respect to the medical care of critically ill 
patients. Those parameters are informative indicators of the conditions of a living system 
and can be valuable in determining the physiologic status of critically ill patients. Tissue 
oxygenation represents the balance between local oxygen delivery and consumption. Under 
resting conditions the level varies between and within organs; it is lower in more 
metabolically active tissues, such as brain (Hou et al., 2003), liver (Vollmar et al., 1992), renal 
cortex and medulla Whitehouse et al., 2006) and higher in tissues with low metabolic rates, 
such as the bladder (Rosser et al., 1995, 1996). Changes in blood carbon dioxide levels are 
associated with myocardial acidosis and alkalosis, ventricular fibrillation and reduced 
myocardial contractility in addition to providing an indication of cardiac resuscitability 
(Maldonado et al., 1993; Tang et al., 1996). The respiratory gases themselves reflect 
cardiopulmonary homeostasis. This is the ability of the cardiopulmonary system to maintain 
a constant relationship between respiration in the cells of the body, the supply of oxygen 
from the lungs to the blood and the elimination of carbon dioxide by the lungs. In this way, 
partial pressures of O2 and CO2 are kept at their normal physiological values. Thus, the 
body constantly consumes oxygen and produces carbon dioxide, and there is a normal 
balance between the absolute contents and the partial pressures of these gases in the blood 
(Hahn, 1998). Although this balance can be upset by many clinical or physiological factors, 
the cardiopulmonary function has a remarkable ability to compensate for these changes, 
especially to maintain the gases at their normal values. The magnitude of the arterial blood 
pCO2 is the key clinical measure of the effectiveness of the lungs to expel CO2. Therefore, it 
is clinically important to measure the inspired and expired partial pressures of both oxygen 
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and carbon dioxide in the critically ill adult and infant patient. It is possible either to take a 
blood sample and analyse this in the laboratory, what is routinely done in hospitals, or to 
perform the measurement in vivo. Although a number of methods are used in the clinical 
setting to measure blood gases, including blood gas analysis and electrodes (Astrup, 1986; 
Harsten, 1988; Suzuki, 1999), some practical issues restrict their use, e.g. the distance of the 
analyzer from the bedside, the need for special training of clinicians and staff for proper 
blood sample collection and handling, potential contamination of blood samples by the 
biological medias and the sensitivity of the method. Thus, there is huge need and interest to 
develop more sensitive and practical methodologies such as optical techniques, especially in 
the field of in vivo intravascular blood-gas analysis (Suzuki, 2001; Tsukada, 2003; Tusa, 2001; 
Wolfbeis, 1991). In vivo gas sensors should respond rapidly, preferably with a response time 
of the order of seconds, if the measurements are to have any significant physiological 
meaning. So far, the only commercially available sensors for the monitoring of adipose 
tissue oxygen partial pressure pO2 are needle-type sensors. Those suffer of the typical 
drawbacks of a point measurement, which is strongly dependent on the position of the 
sensor tip inside the adipose tissue and show high fragility due to the small dimension of 
the sensor heads.  
Combination of the optical sensor with a microdialysis technique is a powerful tool for 
online monitoring of metabolism in tissues (Cooney, 1997, 2000; Ungerstedt, 1991). This is 
mainly due to the fact that the subcutaneous adipose tissue is easily accessible and the risk 
of infection is low. The microdialysis probe, which is a hollow fibre which functions as an 
artificial blood vessel, is inserted into the tissue and is perfused with a dialysis solvent. 
Exchange of substances between the microdialysis probe and the extracellular fluid (sample 
medium) occurs over a semi-permeable membrane. Low molecular weight substances in the 
interstitial fluid surrounding the microdialysis catheter are allowed to diffuse across the 
membrane and to equilibrate with the perfusion solution. The interstitial fluid leaves the 
probe via a side arm from which it is collected (Goossens et al., 2011). Optical sensing 
approach combined with microdialysis have been already used for monitoring of dissolved 
gases and pH in a flow loop (Cooney, 1997, 2000). Pasic et al. (Pasic et al., 2006) have 
described a microdialysis-based glucose-sensing system with an integrated fibre-optic 
hybrid sensor. An important advantage of this system is that for example adipose tissue pO2 
is measured over a much larger area compared to commercially available needle-type 
oxygen sensors.  
In our first work we reported on optical capillary sensors for continuous measurement of 
oxygen and carbon dioxide in subcutaneous tissue using microdialysis for extraction of 
interstitial fluid in subcutaneous tissue (Bizzarri, 2006; Cajlakovic, 2006). The adopted 
sensing scheme for both sensors was phase fluorometry, which is based on the dynamic 
quenching due to oxygen of the photo-excited luminophore Platin(II) meso-
tetra(pentafluorophenyl) porphyrin (Pt-TFPP). In the case of carbon dioxide sensor an ion-
pairing approach combined with dual luminophore referencing as a detection technique 
was used for the preparation of carbon dioxide sensitive layers. The analysis of extracted 
sample by means of the external instrumentation is properly designed for rapid analysis of 
small volumes (less than microliters) and allowed a less invasive technique than the 
intravascular approach (Bizzarri, 2006; Cajlakovic, 2006). Recently, we have presented an 
improved optochemical measurement system for continuous monitoring of adipose tissue 
oxygen tension in biological fluid using a miniaturized flow-through cell instead of a 
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capillary-based sensor coupled to a microdialysis catheter (Bizzarri, 2007; Cajlakovic, 2009). 
The effectivness and accuracy of the sensors were investigated in vitro using physiological 
solution (ringer) and in vivo tests in order to examine the magnitude of changes in tissue gas 
tension in response to evolving shock and resuscitation: 1) on test animals, where 
hemorrhagic schock model has been adopted to simulate critically condition and 2) on 
healthy volunteers, where infusion of adrenaline caused the changes in tissue oxygenation. 
Adipose tissue oxygen tension may be involved in the development of insulin resistance 
(impaired action of the hormone insulin) in humans. Therefore the continuous monitoring 
of adipose tissue oxygen tension (pO2) in individuals affected by obesity and/or type 2 
diabetes mellitus is highly interesting. Recent cell culture and preclinical experiments 
suggest that obesity is accompanied by low levels of oxygen in adipose tissue (Ye et al., 
2007). However, this concept was recently challenged by Goossens et al. (Goossens et al., 
2011), demonstrating increased adipose tissue PO2 in obese insulin resistant compared to 
lean insulin sensitive men. The optochemical sensor technology combined with 
microdialysis is particularly suitable for the development of minimally invasive 
instrumentation for measurement of tissue pO2 (Goossens et al., 2011). In the present 
chapter, we present an improved microdialysis-based oxygen-sensing instrumentation with 
integrated planar sensitive membrane inserted in a miniaturised flow-through-cell (volume 
app. 5μl) for the continuous monitoring of adipose tissue oxygen tension in humans. This 
instrumentation is suitable for measurement at a flow rate as low as 2 µl/min with a 
response time, including the flow time from the catheter to the sensitive membrane, of about 
10 min. The sensor system has been validated in in vivo experiments, in which adipose tissue 
oxygen tension in humans has been monitored under resting conditions and after the local 
administration of a vasoconstrictor and vasodilator (Goossens et al., 2011). As expected, 
local administration of the vasoconstrictor in adipose tissue decreased both adipose tissue 
blood flow and adipose tissue pO2. Subsequently, local infusion of the vasodilator increased 
both adipose tissue blood flow and pO2 values (Goossens et al., 2011). Obtained results 
showed good agreement between the observed adipose tissue oxygen tension and the 
expected behavior due to the induced alteration of adipose tissue blood flow. Thus, this 
system is suitable for in vivo monitoring of pO2 in adipose tissue. 
The second part of this contribution includes the description of the optochemical 
measurement system for simultaneously monitoring of tissue O2 and CO2 partial pressure in 
brain, heart and liver by means of miniaturized implanted fiber optical sensor. pO2 and 
pCO2 measurements are based on the determination of the luminescence lifetime via phase 
modulation fluorometry. The instrumentation unit consists of two independent channels for 
measuring pO2 and pCO2. The O2 sensor is based on the luminescent dye Pt-
pentafluorophenyl-porphyrin, while for CO2 sensor the Resonant Energy Transfer (RET) 
scheme is used to convert the intensity of the analyte dependent dye indicator into long 
luminescence lifetime information, which can be measured by phase modulation 
fluorometry (Lakowicz, 1983). Therewith it was for the first time possible to measure 
continuously and simultaneously O2 and CO2 content in brain, heart and liver during open-
heart surgery. Fiber optical sensors have been tested in an experimental animal model 
during cardiac surgery using two different methods as extra corporal circulation: 
conventional cardiopulmonary bypass (CPB) and minimal extracorporeal circulation 
systems (mini-EEC). CPB is the most accepted surgical technique to treat cardiac 
pathologies. It is a safe and established technique with a low mortality rate (Pentila et al., 
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2001). However, besides neurological events, which may at least be partially related to the 
use of CPB, and the inflammatory response, the ideal myocardial protection is still a matter 
of scientific and clinical debate (Chang, 2002; Immer, 2005; Levy, 2003). Mini-ECC system 
consists of a centrifugal pump, an oxygenator and a modified suction system. The main 
advantage of mini-ECC is the reduction of tubing length (reduction of the priming volume). 
It was designed to reduce blood tubing, the contact between blood and air and priming 
volume during cardiac surgery. The main issue of developing miniaturised extracorporeal 
circulation systems is the strong need for a CPB concept for cardiac surgery which will cause 
fewer traumas to blood components and reduce the extensive volume shifts and bubble 
formation during cardiopulmonary bypass (Kofidis et al., 2008). A closed circuit, where the 
patient himself/herself serves as a reservoir with a minimized priming volume, could be the 
ideal alternative to reduce the adverse effects of CPB (Kamiya et al., 2006). In a complex, 
technically demanding, prospective, randomized and blinded experimental setting, an 
extracorporeal circulation has been performed using mini-EEC versus standard CPB 
techniques with main emphasis on differences in organ specific oxygen and carbon dioxide 
partial pressures and metabolism. In-vivo experiments on animals with implanted optical O2 
and CO2 sensors were performed in order to be able to establish if there is any difference in 
O2/CO2 metabolism when using two types of extracorporeal circulation, CPB and mECC, 
respectively. 
2. The continuous monitoring of adipose tissue oxygen tension (pO2) in 
humans 
2.1 Design of an optical oxygen sensor 
The luminophore Platin(II) meso-tetra(pentafluorophenyl) porphyrin (Pt-TFPP) was used 
because of its long lifetime (∼ 50 ms), strong absorption in green region of the spectrum, 
which is compatible with green light-emitting diodes (LEDs), its highly emissive metal-to-
ligand charge transfer state and its high photostability. The dye was entrapped in a 
hydrophobic polymer of polystyrene (4 w. % dye/g solid polystyrene in chloroform). 
Afterwards the sensor cocktail was spread onto a transparent substrate; either a 
polyethylene terephthalate foils PET (Mylar foil with thickness 100 µm) or PET foils (50 µm 
thickness) coated with Al2O3. Knife coating and screen printing techniques have been used 
for production. After coating, the oxygen sensitive membranes have been dried at 60 °C for 
eight hours. In the case of knife coating a successive mechanical reduction of the sensitive 
spot to a diameter of 2 mm has been applied. This procedure was not necessary in case of 
the screen printed sensitive membranes. 
2.2 Measurement principle  
The luminescence lifetime of a luminophore is an intrinsic property and is independent of 
for example detector sensitivity and fluctuations in light intensity therefore phase 
fluorometry was used as sensing scheme. In this case the luminophore is excited by 
sinusoidally modulated light at a given frequency ω and the emitted sinusoidal 
luminescence is also modulated at the same frequency. The lifetime of the luminophore 
causes a time lag between the absorbance and emission, expressed by the phase angle θ and 
a decreased intensity relative to the incident light, called demodulation. The relationship 
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between the lifetime τ and the phase shift φ for a single exponential decay is given by 









where f is the modulation frequency. An optimal frequency need to be selected because 
signal-to-noise (SNR) ratio decreases and phase sensitivity increases with increasing 
modulation frequency. The used luminophore was Pt-TFPP, whose luminescence is 
dynamic quenched (reduced) in the presence of oxygen and subsequently the lifetime as 
well. The optimal frequency for this dye was chosen 4.5 kHz. The instrumentation measures 
the phase shift of the luminescence with respect to the excitation signal. This is related to the 
luminescence lifetime of the dye, which in turn depends on the pO2 of the tissue in contact 
with the surface of the sensor probe. The pO2 can be calculated from the measured phase 
shift of the luminescence using the so called false-light model (Bizzarri et al., 2006) as 








φ φ ⎡ ⎤+ −⎢ ⎥
+ ⋅⎣ ⎦
  (2) 
where φ is the phase shift measured at a given oxygen partial pressure pO2, φ0 is the phase 
shift in absence of O2, K is the quenching parameter and f0 is the false-light parameter (the 
fraction of the luminescence emitted by the sensor, which is quenched by oxygen). 
 
Fig. 1. Principle of phase fluorimetric technique. Luminescence emission is delayed in phase 
angle Φ and demodulated relative to the excitation (m). 
2.3 Miniaturised flow-through cell and optoelectronic measurement unit 
The fibre optic measurement system consists of an optoelectronic read-out module for 
measurements with optical fibres (core diameter 1000 µm) and of a miniaturised flow-
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through cell (volume app. 5 µl), where a planar oxygen sensitive membrane (diameter of the 
sensitive spot 2 mm) is allocated. The measurement set-up is shown in Fig. 2. The flow 
through cell is equipped with inlet tubing of inner diameter of 0.15 mm and outer diameter 
of 0.30 mm (Rometch GmbH). The outlet tubing and the flow chamber have an inner 
diameter of 2.0 mm. The outer diameter of the outlet tubing is 3.0 mm as presented in Fig. 3. 
The inner diameter of the inlet was chosen to be 0.15 mm in order to match the inner 
diameter of the inlet of the microfluidic catheter. This geometry has been chosen to reduce 
the risk of overpressure during measurement, which would cause an overestimation of the 
dissolved pO2. The length of the inlet is 20 mm whereas the outlet is 32 mm long. The 
tubings are made of stainless steel in order to prevent or to reduce the permeation of 
ambient oxygen to non-significant values. 
 
Fig. 2. Measurement system for planar sensing membranes. The flow-through cell has a size 
of 20 x 13 x 4.8 mm (length x width x heigth). The measuring chamber of the flow-through-
cell has a diameter of circa  1.8 mm and a height of about 2.8 mm, thus resulting in a volume 
of about 5 µl. The sensing membranes have a round sensitive spot of 1.8 mm in diameter. 
 
Fig. 3. Schematic draw of the flow through cell 
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The optic set-up is integrated in the processing electronic unit and is based on a collimating 
optics, which converts the light of the excitation source (a Nichia NSPE590S LED) into a 
parallel beam. This is then focused by a GRIN lens into an optic fibre, which guides the 
excitation light to the oxygen sensitive layer inside the flow-through cell. The luminescence 
collected by the same optic fibre is deflected by a dichroic filter at 45 ° (DC Red, Qioptiq 
Photonics GmbH & Co. KG) towards the detector a silicon photodiode (Hamamatsu S5106). 
A set of optical filters (SCHOTT BG39, thickness 2 mm, for the excitation source and 
SCHOTT RG630, thickness 2 mm, for the photodiode) is used to separate the luminescence 
signal from the excitation light and other optical background signals (e.g. luminescence 
emitted by materials close to the O2 sensitive membrane). A reference light source (Nichia 
NSPE590S LED) is used to compensate the reading of the measuring unit for changes of the 
electronic parameters of the components with fluctuations of the operating conditions (e.g. 
forward current through the LED and temperature). The main advantage of using fiber optic 
technology is the possibility to separate the optoelectronic instrumentation from the flow-
through cell, thus allowing an extreme miniaturization of the cell itself. The new flow-
through-cell has size of only 20 x 13 x 4.8 mm, which makes it more flexible for use in in vivo 
experiments and use in hospitals. In order to prevent disconnection of the fluidic when the 
patient moves the flow-through cell was mounted on a belt for fixed positioning on the 
abdomen of the subject during in vivo experiment, as it is shown in Fig. 4. 
 
Fig. 4. Use of the optochemical oxygen sensor instrumentation during a typical in vivo 
experiment. The main components are the flow-through-cell, which is fixed near the 
umbilicus of the volunteer close to the position of insertion of the CMA 60 microdialysis 
catheter. The luminescence emitted by the oxygen sensitive membrane is collected by an 
optic fibre cable and guided to the optoelectronic read-out unit. The microdialysis probe is 
perfused using a microinfusion syringe pump. These experiments were carried out in the 
laboratory of Dr. G.H. Goossens (Maastricht University Medical Centre, The Netherlands). 
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For the extraction of interstitial fluid microdialysis catheter CMA60 was used. The outlet 
tubing of catheter was first cut as close as possible to the microdialysis membrane (at a 
distance of about 2 mm) and then connected with the flow through cell by means of steel 
tubing (diameters 0.15/0.30 mm). The length of the steel tubing was standardised at 90 mm 
in each experiment. In this way the ambient oxygen diffusion through the permeable tubing 
materials of the catheter can be neglected. This has been proven in oxygen recovery rate 
measurements, which have been carried out in laboratory. These measurements have been 
already exhaustively described in previously reported work (Cajlakovic et al., 2009). The 
standardization of the length of all the connection tubing allows that the flow time from the 
catheter to the sensitive membrane is in all experiments the same. 
2.4 Applications and practical systems 
2.4.1 Sensor performance and laboratory calibration protocol 
The membranes have been produced by knife coating technique onto PET substrate and by 
means of screen printing onto PET substrate coated with Al2O3 as oxygen barrier. 
All sensor membranes have been firstly laboratory characterized in Ringer solution 
(physiological solution used as perfusate in many clinical procedures) at temperature held 
constant at 37 °C. The temperature regulation was realised by using a water bath thermostat 
(Lauda RC 6 CP). The measurement medium has been equilibrated with a gas mixture of 
nitrogen and oxygen at defined concentrations (typically 0, 5, 10 and 21 % O2) using a mass 
flow controller (Bronkhorst, The Netherlands). A paramagnetic gas purity analyser 
(Servomex, U.K.) was served as reference instrumentation. The solution was then pumped 
by means of a peristaltic pump into a miniaturised flow-through cell at the flow rate of 2.0 
µl/min (Minipuls 3, Gilson, Germany). One example of a typical sensor response curve, 
phase angle as a function of different O2 concentrations, is shown in Fig. 5.  
 
Fig. 5. Example of the experimental protocol used for the characterisation of the 
miniaturised planar O2 sensitive membrane. The measurement is carried out in Ringer 
solution equilibrated at defined O2 concentrations (0, 5, 10 and 21 % O2) at the constant 
temperature of 37 °C. 
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Two cycles have been performed, whereas the first complete cycle of dissolved O2 was used 
for sensor calibration purpose, and the following cycle is used to check the specifications of 
the oxygen measurement (Table 1).  
 
 Specifications 
Working range 0-300 mmHg 
Resolution 1 mmHg 
Accuracy < 7% or ±1 mmHg 
Table 1. Achieved specifications of the O2 measurement with planar sensitive membranes 
compared to the optimum requirements defined in the project 
Both types of membranes perform satisfactorily with the same measurement specifications. 
2.4.2 Delay time 
The time needed for the extracted interstitial fluid to reach the sensitive oxygen membrane 
in the flow-through cell is indicated as delay time. This delay time is defined as the time 
required for the sensor output to change from its previous state to a final settled value 
within a tolerance band of the new value. It is a common practice to measure the delay time 
as the time needed for the sensor to reach the 90 % of the final output. This is usually 
indicated as the t90 of the sensor. Fig. 6 shows the delay time t90 for an oxygen change from 
air saturated solution (circa 21 % O2) to oxygen free solution (about 0 %). 
 
Fig. 6. Measured delay time between 21 and 0 % of O2 in case of one oxygen sensitive 
membrane 
To perform this measurement, two different glass vessels filled with Ringer solution has 
been equilibrated with air and nitrogen. The catheter CMA 60 connected by steel tubing to 
the flow through cell has been first immersed in the vessel containing air saturated Ringer 
solution and the peristaltic pump was started with flow rate of 2 µl/min. After a stable 
value of the oxygen sensor instrumentation has been achieved, the pump has been shortly 
stopped to change the catheter in the oxygen free Ringer solution and the flow started again. 
The time needed to achieve the 90% of the final value as been recorded. Six different 
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membranes of both types have been investigated and the averaged t90 could be estimated as 
11.7 ± 4.6 min. Even if, the two different types of sensitive membranes (based on uncoated 
or Al2O3 coated PET substrate) perform satisfactorily with regard to the measurement 
specifications, it could be observed that, in single membranes based on the uncoated PET 
substrate, the response time increased above the specified time of 10 min, due to ambient 
oxygen diffusion through microscopic damages of the coated surface, caused by the 
mechanical reduction of the sensitive spot. 
2.4.3 Clinical validation in humans 
2.4.3.1 Validation protocol 
To validate the sensor instrumentation for in vivo use in humans, a healthy, normal-weight 
male subject participated in an experiment carried out at Maastricht University Medical 
Centre in The Netherlands. The subject was asked to refrain from drinking alcohol and to 
perform no strenuous exercise for a period of 48 hours before the in vivo experiment. On 
arrival, a microdialysis catheter (CMA 60, CMA microdialysis AB, Stockholm, Sweden) was 
inserted in the abdominal subcutaneous adipose tissue 6 cm right from the umbilicus after 
the skin was anesthetized by a lidocaine/prilocaine cream (EMLA, AstraZeneca BV, 
Zoetermeer, The Netherlands). After insertion, the probe was perfused with Ringer solution 
(Baxter BV, Utrecht, The Netherlands), supplemented with 50 mM ethanol, at a flow rate of 
2.0 µl/min (CMA400 micro infusion pump, CMA microdialysis AB, Stockholm, Sweden). 
Afterwards, the system was allowed to equilibrate. After pO2 had reached stable values, the 
probe was consecutively perfused with a vasoconstrictor and vasodilator, each for 60 min. 
There was a wash-out period of 120 min (Ringer infusion) before the infusion of the 
vasodilator was started. 
2.4.3.2 Results and discussion of in vivo measurement of adipose tissue oxygen tension in 
humans 
A stable baseline pO2 of 52.5 mmHg was reached after 2-3 hours (Fig. 7, time -30 to 0 min). 
As hypothesized, local administration of a vasoconstrictor in adipose tissue (t0-60 min) 
decreased both adipose tissue blood flow and adipose tissue pO2 (37.3 mmHg, Figure 7). 
During the wash-out period (t60-180min) the probe was perfused with Ringer solution, and 
pO2 values returned to near-baseline values again (53.5 mmHg). Subsequently, local infusion 
of a vasodilator increased both adipose tissue blood flow and pO2 values to 74.8 mmHg 
(t180-240min). This experiment clearly showed that pO2 values can be reliably measured in 
vivo in humans, and can be modified by changes in tissue blood flow. These results have 
been extensively described elsewhere (Goossens et al., 2011).  
The rapid increase of the measured pO2 at the beginning of each drug administration (spikes 
in Fig.7) is caused by ambient oxygen, which has been introduced in the fluidic during the 
change of the infusion solution. 
After the in vivo experiments several oxygen sensitive membranes were recalibrated in the 
laboratory, and the deviations of the pO2 values obtained by the second calibration were 
calculated and plotted against the actual pO2 values (Fig. 8). Importantly, the change in the 
calibration of the sensitive membrane after the in vivo experiment causes very small 
discrepancy (<0.5 mmHg) from the actual pO2 values. This result is excellent considering 
that the oxygen sensitive membranes have been recalibrated about one year after the first 
laboratory calibration and after in vivo experiments of a typical duration of 5 – 8 hours. 
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Fig. 7. Measured abdominal adipose tissue pO2 with optochemical sensitive membrane 
under stable baseline conditions (local Ringer administration up to time 0), during local 
administration (2 µl/min) of a vasoconstrictor between 0 and 60 min, followed by wash-out 
period with Ringer infusion (from 60 to 180 min). At 180 min an infusion of a vasodilator 
was started up to 240 min. The experiment was carried out in the laboratory of Dr. G.H. 
Goossens (Maastricht University Medical Centre, The Netherlands) (Goossens et al., 2011). 
 
Fig. 8. Deviations of the pO2 values measured for single oxygen sensitive membrane after in 
vivo experiments compared to the calibration values. 
www.intechopen.com




We have developed and validated a microdialysis-based oxygen-sensing instrumentation 
with integrated miniaturized sensitive membrane for the continuous monitoring of adipose 
tissue oxygen tension in humans. In comparison to previously reported instrumentation 
(Cajlakovic et al., 2009), this system can be used at a flow rate as low as 2 µl/min with a 
response time of about 10 min (including the flow time from the catheter to the sensitive 
membrane). The production technology of the oxygen sensitive membranes has been 
improved, allowing the pO2 measurement in the range between 0 and 300 mmHg with 
accuracy better than ±1 mmHg and resolution better than 1 mmHg. The system has been 
validated in vivo, where adipose tissue oxygen tension has been monitored in humans under 
resting conditions and during local administration of vasoactive compounds. Local 
administration of the vasoconstrictor in adipose tissue decreased adipose tissue pO2 and 
subsequently, local infusion of the vasodilator increased pO2 in adipose tissue (Goossens et 
al., 2011). The agreement between the observed adipose tissue oxygen tension and the 
expected behaviour after modulation of adipose tissue blood flow allows concluding that 
the system is suitable for in vivo monitoring of pO2 in humans. Several sensitive membranes 
were recalibrated after in vivo experiments in the laboratory and deviations smaller than ± 
0.5 mmHg were observed. This indicates that the membranes have an excellent storage and 
operating stability, and that contact with biological fluid does not affect the read-out of the 
optochemical measurement instrumentation. 
2.6 Acknowledgement 
The in vivo experiments in humans were carried out at Maastricht University Medical 
Centre, Maastricht, The Netherlands, under supervision of Dr. G. H. Goossens.  
3. Optochemical measurement system for simultaneously monitoring of O2 
and CO2 partial pressure in vital organs by means of miniaturized implanted 
fibre optical sensor 
The measurement system is composed of two channels allowing simultaneously measuring 
of O2 and CO2 partial pressures (pO2 and pCO2). The optoelectronic measurement unit for O2 
is same as described in chapter 2 (Paragraph 2.3). For this application optical fibres were 
coated with sensitive layers (O2 and CO2). In the case of using an optical fibre as support for 
the sensitive layer, pulses of light emitted by a green (in the case of O2 sensor) or blue LED 
(in the case of CO2 sensor) are carried via an optical fiber to excite the dye at the sensor tip. 
On interaction with measured parameter the luminescence is quenched and is transmitted 
back within the same fibre to the detection unit. The instrumentation measures the phase 
shift of the luminescence with respect to the excitation signal. 
3.1 Optoelectronic measurement unit for CO2 
As in the case of the O2 measurement channel a measurement system for CO2 is based on a 
collimating optics to convert the light of excitation source (Nichia NSPB500) into a parallel 
beam, which can be focused by a GRIN lens into the optic fibre. The luminescence collected 
by the optic fibre is also transformed by the same GRIN lens into a parallel beam, which is 
deflected by a dichroic filter at 45 ° (Unaxis B51) with respect to the optical axis to the silicon 
photodiode as a photo-detector (Hamamatsu  S5106). Dichroic filters transmit selected 
ranges of the visible spectrum and reflect the complementary ranges, thus they may be used 
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to separate the radiation emitted by the excitation source from the luminescence. Additional 
glass optical filters (SCHOTT BG12, thickness 2 mm for the excitation source and SCHOTT 
KV550, thickness 3 mm as emission filter) are used to separate the luminescence from stray 
light and optical background due to the excitation source. For the compensation of the 
reading of the measurement unit for changes of the electronic parameters of the components 
with fluctuations of the operating conditions (e.g. forward current through the LED and 
temperature) a reference light source is used (HLMA-KL00-I0000 (Avago Technologies US 
Inc.). The excitation light of the LED was sine wave modulated at a frequency f of 20 kHz.  
3.2 Optical fiber tip micro fabrication by chemical etching 
The most efficient configuration of optical fibre for collecting the luminescence emission and 
to reduce the optical background was achieved by coating the sensitive layers onto the 
sharpened tip of optic cables with core diameter of 400 and 200 µm. For this purpose the 
fiber tips have been micro-machined by chemically etching process (tube etching) of multi-
mode optical fibers (Si core and hard polymer cladding, Thorlabs). The schematic 
illustration of the forming of a sharpened fiber tip is presented in Fig. 9. After the etching 
process was completed, the tip of the optical fiber was rinsed with distilled water and 
cleaned with acetone. The height of the obtained cone tip is about 1.5 mm. All the etching 
experiments were carried out at room temperature. The obtained form of an optical fibre 
efficiently resulted in improved signal-to-noise ratio of about one order of magnitude for 
both types of sensors thus resulted in an increased luminescence signal. 
 
Fig. 9. Top: (a) immersion of a fiber tip into the etchant-organic solution (40 % hydrofluoric 
acid-toluene); (b) pull out of the fibre until a meniscus is formed at the interface; (c) the 
meniscus height reduces progressively until the portion of the fiber below the organic solvent 
is completely etched (d). Below: formed a cone-shaped tip with an angle between 15 – 20 °. 
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3.3 Preparation of O2 fiber optical sensor 
The sensitive cocktail is composed of Pt-TFPP dissolved in polystyrene (4 w. % dye/g solid 
polystyrene in chloroform). The optical fibres were coated by dipping only the sharpened 
tip of the fibre into a sensitive cocktail. After coating, the oxygen sensors have been dried at 
60 °C for eight hours. 
3.4 Preparation of CO2 sensing cocktail 
The carbon dioxide sensitive cocktails were prepared by mixing donor and acceptor dye, 
along with a phase transfer agent, tetraocytlammonium hydroxide (TOAOH) in 
ethylcellulose solution and coating a sensitive thin film onto the tip of etched optical fiber. 
The polymer solution of ethyl cellulose (EC) was prepared by dissolving 4.4 g of EC in the 
40 g of a toluene/ethanol mixture (80/20, v/v), giving a viscous 11 % (w/w) solution. 
Ru(dpp) nanobeads incorporated in oxygen impermeable polymer, polyacrilonitrile (PAN) 
have been suspended in polymer (EC) solution. Acceptor was prepared by dissolving 2.03 
mg of phenol red (PR) in 1.5 ml of toluene/ethanol mixture to which 20 µl of TOA-OH (20 % 
solution in methanol) solution was added. The rate of energy transfer and therefore the 
sensitivity of the sensor are almost independent of the concentration of the donor in the 
matrix. However, an increase in donor concentration enhances the luminescence intensity 
and therefore the signal-to-noise ratio. In contrary, the concentration of the deprotonated 
form of acceptor is a decisive factor upon which the rate of energy transfer strongly depends 
since the overlap integral is proportional to the concentration of the acceptor in Förster 
equation. Owing to this, the signal change depends not only on the degree of protonation by 
carbon dioxide but also on the overall concentration of the acceptor in the sensor membrane. 
Therefore, the final cocktail composition consisted of 13.8 mmol Ru(dpp) and 3.08 mmol PR 
per kg of solid polymer. The cocktails were saturated with carbon dioxide before coating of 
the fiber tip. The resulting fiber optical sensors were dried for 4 hours at 70 °C before an 
additional ion impermeable layer of Teflon with added black graphite as an optical and 
protective isolation was applied. The dried sensors were stored in desiccator over sodium 
carbonate before use. Before the calibration was proceeded the optical fibers have been 
exposed to solution equilibrated with CO2 (20 %) and N2 in order to obtain faster stable 
response of the sensor. 
3.5 Measuring principle of CO2 optical sensor 
For the realisation of an optical lifetime-based CO2 sensor, whose luminescence and lifetime 
are modulated by pH dependent efficiency of resonance energy transfer, some criteria need 
to be considered at selection suitable donor-acceptor pairs: (a) a pH-sensitive indicator is 
combined with long-lived transition metal complex; (b) an absorbance spectrum of 
deprotonated form of analyte dependent pH-indicator has to overlap with the luminescence 
spectrum of the inert luminophore, added as a donor so that efficient energy transfer takes a 
place; (c) the distance between donor and acceptor does not exceed Förster distance (in the 
range 1-10 nm), (d) lifetime of the donor in microsecond range (e) high quantum yield of the 
donor and (f) excitation of the acceptor and donor at a single band of wavelength and 
detection of donor luminescence at a common wavelength using a single photodetector. In 
order to convert a change in absorption spectrum of acceptor in presence of CO2 into lifetime 
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information, a long-lifetime luminescent donor need to be co-immobilised in the same 
matrix. Depending on the pH, the acceptor changes its colour and deactivates the excited 
state of the donor. This effect changes both the luminescence intensity and the lifetime of the 
donor. Ru(II) diphenyl-phenanthroline (Ru(dpp)) was selected as a donor due to the high 
quantum yield (0.6) and long lifetime in range of microseconds (∼ 5.5 µs). Its absorption 
spectrum perfectly overlaps the emission of bright blue LEDs and its red emission spectrum 
overlaps the absorption of the deprotonated form of pH-indicators in red region of 
spectrum. Among the investigated pH indicators the main problem was their poor 
photostability (for example for the case of cresol purple and bromothymol blue) and due to 
the pronounced photobleaching these indicators turned out to be not suitable for the fiber 
optic measurement system. Even the strategy of optimising the ratio between the 
concentrations of pH indicator in comparison to the concentration of the donor did not 
allow realising a sensor with satisfactorily stability properties. Therefore on the basis of 
enough overlapping of the absorption spectrum of deprotonated form of phenol red (i.e. in 
absence of CO2) with luminescence of Ru(dpp) phenol red was chosen as an acceptor (Fig. 
10) . This dye provides enough intensity when the energy transfer with Ru(dpp) takes place, 
has pKa value in the physiological range (6.8)  and expand the measurement range up to 20 
% of CO2 (corresponding to 147 mmHg). 
 
Fig. 10. Luminescence emission spectrum of Ru(dpp)32+ (solid line) and absorption spectra 
of phenol red in the absence (dashed line) and presence (dotted line) of CO2 (20 %). The 
hatched area indicates the spectral overlap of the donor emission and acceptor absorption. 
The CO2 sensor is solid type sensor, what means that no buffer was used. Instead this the 
pH indicator (A) forms a hydrated ion-pair (A−Q+·xH2O) by an addition of quaternary 
ammonium base (Q+OH−) (Mills et al., 1992). To stabilize the deprotonated form of the 
indicator dye in the matrix and to form a lipophilic bicarbonate buffer system in the 
polymer, tetraoctyl ammonium hydroxide was used. The excess amount of TOA-OH is 
neutralised by atmospheric carbon dioxide to form a lipophilic hydrogen carbonate buffer in 
the solid matrix, and this can tune the sensitivity and improve the storage stability of the 
sensor. The sensing mechanism of an acceptor-Q+OH ion-pair is described by (3): 
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 ( )2 2 3 2TOA A .xH O  CO TOA HCO . x 1  H O  AH+ − + −+ ↔ − +  (3) 
where [TOA+A-. xH2O] is the complex of the deprotonated pH indicator dye ion paired with 
the quaternery ammonium cation TOA+ and a number x means the hydrophilic sites present 
in the polymer matrix.  
In the case of Resonance Energy Transfer (RET) as sensing scheme the average lifetime is 
converted into a parameter (phase angle) that reflects the concentration of deprotonated pH-
indicator (acceptor). The CO2 dependent lifetime information is detected using the technique 
of phase fluorometry. In this technique, the lifetime data (τ) are converted to phase shift data 
(φ) as it was described by equation (1).  











where kRET is rate of resonance energy transfer and kother is the sum of the rates of all other 
deactivation processes including luminescence. τmax reflects the lifetime of donor (complete 
protonation of acceptor at very high pCO2, when no energy transfer occurs) and τ is a 
lifetime in the absence of carbon dioxide. By rearrangement of the equation 4 the ratio τmax/τ 
can be expressed as: 







= = +  (5) 
From Förster theory it follows, that the rate of energy transfer kT is proportional to the 
spectral overlap integral J between donor emission and acceptor absorption (kT ∝ J). When 
the pH-indicator is completely completely protonated, there is no spectral overlap with the 
donor and overlap integral J is proportional to concentration of deprotonated dye D-: 








− = ≅ ≅ ⎣ ⎦  (6) 
This model corresponds to the situation of dynamic quenching of luminescence described 
by the Stern-Volmer equation. Therefore pCO2 was calculated from the measured phase shift 
of the luminescence using as described by equation (7): 







⎡ ⎤φ = φ + −⎢ ⎥
+ ⋅⎣ ⎦
 φ ൌ φ଴ ቂ ௙బଵା௄⋅௣஼ைమ ൅ 1 െ ଴݂ቃ (7) 
3.6 Laboratory calibration protocol 
Before of the in vivo measurements, the fiber optical pO2 and pCO2 sensors have been 
calibrated in laboratory. In the case of pO2 sensors, a glass vessel filled with Ringer 
solution and kept in a water bath (Lauda RC 6 CP thermostat) at the constant temperature 
of 37 °C has been equilibrated with a gas mixture of nitrogen/oxygen at defined 
www.intechopen.com
Optochemical Sensor Systems for In-Vivo Continuous  
Monitoring of Blood Gases in Adipose Tissue and in Vital Organs 
 
79 
concentrations (typically 0, 5, 10 and 21 % O2) using a mass flow controller (Bronkhorst, 
The Netherlands). Similarly, in the case of the pCO2 sensors the Ringer solution has been 
equilibrated with a gas mixture of nitrogen/carbon dioxide at defined concentrations 
(typically 0, 5, 10, 15 and 20 % CO2). A gas purity analyzer (Servomex) with both a 
paramagnetic O2 sensor and a CO2 infrared sensor has been used as reference to analyse 
the composition of the gas mixture dissolved in the Ringer solution. The fiber optic 
sensors have been put in contact with the Ringer solution and the phase shift at each 
defined gas concentration has been recorded. An example of the phase shift response at 
exposed gas concentration is shown in Fig. 11 for pO2 sensors and in Fig. 12 for pCO2 
sensors, respectively. It can be seen that for both sensors usually two cycles of dissolved 
O2 and CO2 concentrations have been measured. The first cycle has been used for sensor 
calibration purpose, whereas the following cycle is used to check the specifications of the 
oxygen and carbon dioxide measurements calculated with calibration parameters 
obtained from equations 2 and 7, respectively.  

















































pO2 [mmHg]  
Fig. 11. Oxygen sensor response curve, phase angle as a function of different O2 
concentrations; below: calibration curve obtained by the first cycle of dissolved oxygen 
concentrations. 
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pCO2 [mmHg]  
Fig. 12. Carbon dioxide response curve, phase angle as a function of different CO2 
concentrations; below: calibration curve obtained by the first cycle of dissolved CO2 
concentrations. 
3.7 In vivo pO2 and pCO2 measurements on animal by use of fiber optical sensors 
In vivo experiments on test animals have been performed at the Medical Univeristy Graz, 
Clinical Department of Heart Surgery. Fourteen pigs (30.7 + 2.5 kg) were investigated by 
monitoring the pO2 and pCO2 content in tissue of the three vital organs: brain, heart and 
liver in order to examine the oxygen delivery to the tissue of these organs during simulated 
heart surgery operations. Heart surgery intervention is necessary to heal and treat cardiac 
defect or valvular heart diseases. During this kind of surgeries an extracorporeal blood 
circulation can be carried out using the so-called “heart lung machine” (HLM) which 
temporarily takes over the functions of the heart and lungs during surgeries, maintaining 
the circulation of blood in the body. A heart lung machine maintains perfusion to other 
body organs and tissues while the surgeon works in a bloodless surgical field.  
The aim of test on animals was the simultaneously evaluation of pO2/pCO2 exchanges in 
three vital organs: brain, heart and liver using two different methods of extra corporal 
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circulation: conventionally cardiopulmonary bypass (CPB) and Minimal Extra Corporal 
Circulation (MECC) (see Fig. 13). The questions that appeared were: are the optical fiber 
sensors suitable for the evaluation of metabolic variables and organ specific O2/CO2 
exchanges during heart surgery and furthermore, is it on the basis of the obtained results 
capable to estimate difference between CPB and MECC? 
  
Fig. 13. CPB (left) and MECC (right) 
3.7.1 Experimental protocol  
pO2 and pCO2 have been measured continuously with fiber optical sensors previously 
calibrated in laboratory and checked again before the in vivo measurements, directly at the 
place of the in vivo measurements. In order to protect the fragile tip of the optical fibers and 
to position the two type of sensors as near as possible to each other at the local place of the 
measurement, each sensor (one pO2 and one pCO2) was inserted in the needle (inner 
diameter of 500 mm) and then implanted into the tissue of the organ. Firstly, a drill hole has 
been made in temporal region of the skull above ear in order to insert a needle containing 
the optical pO2 and pCO2 sensors deeply into the brain tissue. In this region is the skull of 
pigs thinnest due to the thickness of bones. Afterwards was the thorax and abdomen 
opened to insert the optical sensors into the liver and finally into heart tissue. After baseline 
measurements (recording of the first blood values and the first values obtained with the 
optical sensors) the aorta was cross clamped for a period of 60 min and the HLM was put 
into operation. The blood values and the tissue values of pO2 and pCO2 have been taken at 
intervals of time of 15 minutes. After one hour of operation the clamps of the HLM have 
been removed and the heart has been reanimated for 30 minutes. The physical state of the 
animal has been monitored another half of hour before the experiment ended. The exact 
study protocol is shown in Table 2: 
www.intechopen.com




T1 Baseline before connection of HLM under physiologic conditions 
T2 During cooling on HLM after 15 min (then cross clamping of aorta) 
T3 15 min after cross clamping the aorta
T4 30 min after cross clamping the aorta
T5 45 min after cross clamping the aorta (then rewarming) 
T6 60 min after cross clamping the aorta ( then de clamping of aorta) 
T7 15 min after normothermic reperfusion
T8 30 min after normothermic reperfusion (off-HLM)
T9 15 min after end of using of HLM
T10 30 min after end of HLM (end of experiment)
Table 2. Protocol of in vivo experiments 
3.7.2 Results of in vivo experiments 
Since the brain tissue perfusion is one of the most important substrate for energy 
metabolism delivered by the blood, an example of pO2 and pCO2 profiles measured by fiber 
optical sensor in this organ are shown in Fig. 14. Despite the very low pO2 values at the 
beginning of the measurement, a slightly decrease in pO2 value during HLM can be 
observed, followed by an increase up to 55 mmHg during recirculation. On the contrary, 
pCO2 increases up to 40 mmHg during HLM and after recirculation reaches the same value 
as at the beginning (10 mmHg). These measurements confirmed a heterogeneous 
distribution of local pO2 and pCO2 values in brain. The tissue concentration is determined by 
the balance between supply and utilisation and the anatomical distribution of concentration 
and within the brain was reported to be wide, depending on the depth of penetration of the 
sensor into the tissue (Luebbers & Baumgaertl, 1997). The pO2 and pCO2 responses as shown 
in Fig. 14 have an opposite trend which is in agreement with medical point of view that 
anaerobic condition of tissue correlate with increase of CO2 content.  
The supply of brain with oxygen depends on the cerebral perfusion and on difference 
between arterial and venous O2 partial pressures. CO2 partial pressure has a significant 
influence on the blood circulation in the brain. When the arterial CO2 partial pressure paCO2 
increases, pCO2 in brain increases proportional with this increment. If on the contrary 
Hyperventilation causes a decrease of pCO2 down to 20 mmHg, than a cerebral Hypoxia and 
increased cerebral Lactacidose is provoked due to the vasoconstriction.  
Despite the fact that brain are very active organ with higher oxygen and energy demand, 
low pO2 values below 10 mmHg has been often measured. Such sensor behavior could be 
obtained due to the influence of the narcosis on the brain activity and due to the position of 
the sensor tip in brain. Latter can result in holes by implantation of the optical sensor probes 
into brain region since the brain consists of the tissue and the hollow spaces. As a 
consequence of the positioning of the optical fiber in hollow spaces, lower pO2 values can be 
obtained during measurements in brain. 
Fig. 15 and 16 show oxygen and carbon dioxide profile in liver and heart, respectively. In 
vivo measurements in liver reflected lower pO2 values before HLM was put into an 
operation (pO2 values app. 5 mmHg) and afterwards a decrease of pO2 vales in the range of 
1.5 mmHg. After corporal recovery, the pO2 values reach the value at the beginning of the 
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measurement. Similarly, pCO2 values in liver are at beginning of 8 – 10 mmHg, and during 
HLM operation an increase in pCO2 has been noticed (app. 13 mmHg). After recirculation 
pCO2 reaches the values similar at the beginning of the experiment (8 mm Hg).  
 
Fig. 14. In vivo measurement in brain obtained with inserted pO2 and pCO2 fiber optical 
micro sensors: red line indicates the start of functionality of HLM, while green line indicates 
the return to the normal intra-corporeal circulation. The x scale shows the real time of the 
measurement, so it can be seen that the experiment has started at about 9:30 am and ended 
few minutes after 13:00 for an overall duration of less than 4 hours. 
 
Fig. 15. In vivo measurement in liver obtained with inserted pO2 and pCO2 fiber optical micro 
sensors: red line indicates the start of functionality of HLM, while green line indicates the 
return to the normal intra-corporeal circulation. 
For the comparison of all performed in vivo experiments on animals using either CPB or 
MECC as extracorporeal circulation system the measured pO2 and pCO2 values were 
statistically arranged with a two way analysis of variance (ANOVA) model. The measured 
parameters were normalized to the initial values at a level of 100 % due to the high 
variances of initial values of those variables measured with optical sensors (pO2, pCO2). 
Those results are shown in Fig. 17 to 19 for the brain, liver and heart, respectively. 
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Fig. 16. In vivo measurement in heart obtained with inserted pO2 and pCO2 fiber optical 
micro sensors: red line indicates the start of functionality of HLM, while green line indicates 
the return to the normal intra-corporeal circulation. 
 
Fig. 17. Comparison of the values measured with optical fibers and normalized to the initial 
values at a level of 100 % for in vivo measurements in brain. 
 
Fig. 18. Comparison of the values measured with optical fibers and normalized to the initial 
values at a level of 100 % for in vivo measurements in liver. 
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Fig. 19. Comparison of the values measured with optical fibers and normalized to the initial 
values at a level of 100 % for in vivo measurements in heart. 
The above Figures indicate on the similar trends of pO2 and pCO2 curves for both 
extracorporeal circulation systems. It is shown that under standardised conditions pO2 curves 
in brain were absolutely higher in the case of mini-ECC. In the case of liver it was found that 
under standardised conditions intrahepatic parenchymal pCO2 curves were absolutely higher 
and they are significantly correlated to arterial and central venous lactate in CPB.  
3.8 Conclusions 
In the presented work a novel combined optochemical measurement system which allows a 
simultaneously measurement of dissolved oxygen and carbon dioxide in tissue of vital 
organs is described. The tissue oxygenation is frequently monitored with electrochemical 
micro sensors (e.g. polarographic needle electrodes) which one limitation is that due to the 
oxygen consumption during pO2 measurements, the probe needs to be moved through the 
tissue (Lowry & Fillenz, 2001; Luebbers, 1996, Nair, 1987). On the contrary fiber optic probe 
can be left in the same position in the tissue for a prolonged period of time because is non-
invasive. This makes it possible to directly temporal changes in pO2 as well as the 
oxygenation-modifying interventions over time in a tissue. Furthermore, optochemical 
sensors based on luminescence intensity show higher sensitivity and the use of phase 
modulation fluorometry as measuring techniques for both oxygen and carbon dioxide 
sensors enable the realisation of optical sensors with excellent characteristics of reliability 
and measurement stability possible superior to those of electrodes. Further advantage of 
optical sensors over the electrodes is ease of miniaturisation. In presented work tapered 
optical fiber tips obtained through chemically etching improved the signal-to-noise ratio of 
about one order of magnitude. Based on this fact further miniaturisation can be achieved, 
using a fiber optical cables with smaller diameter (e.g. 50 µm). This type of the optical 
sensors also offers a possibility to use them for endoscopy. Furthermore, the described 
optical sensors are almost calibration free using only one point recalibration.   
Despite the fact, that the last years are witnessed to an increased number of optochemical 
oxygen sensors based on phase modulation fluorometry in field of medical applications, 
especially for analysing the spatial heterogeneity in oxygen tension in tumor tissue using 
optical oxygen probes OxyLite (Oxford Optronix, Oxford, UK), at present and up to our 
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knowledge there has been no reports about fiber optical CO2 sensors for measuring pCO2 
content in tissue of organs.  
The described optochemical instrumentation has been used in in vivo tests for 
simultaneously detection of oxygen and carbon dioxide exchange in brain, heart and liver 
using two different methods as extra corporal circulation: Minimal Extra corporal 
Circulation (MECC) and Cardiopulmonary bypass (CPB). It has been turned out that a 
significantly higher demand of blood transfusion is required and higher lactate values 
(correlated to higher pCO2 values) are observed when using classical method CPB. The 
continuous acquisition of metabolic parameters (pO2 and pCO2) has showed that in the case 
of using MECC as extra corporal circulation, significantly higher pO2 values are obtained, 
while the use CPB resulted in significantly higher pCO2 in liver and heart tissue.  
It is demonstrated that with a help of miniaturised non-invasive fiber optical sensors for 
continuously measurement of tissue pO2 and pCO2 a significant better O2/CO2 metabolism 
is achieved in the case of MECC as extra corporal circulation. Furthermore, MECC produced 
less lactate and showed significantly favourable results concerning O2/CO2 metabolism and 
transfusion demand. 
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